ROCKVILLE, Md., March 20, 2017 /PRNewswire/ -- Roche, Alere, Abbott, Siemens are among the largest companies in point of care (POC) diagnostics in terms of revenues, according to Kalorama Information. Point-of-care systems are designed to deliver test results in a location and timing to be useful during a patient visit. They consist of devices such as glucose meters, operated by a patient, or small analyzers operated in a physician office lab. Together these companies make up three-fourths of the entire market for point of care diagnostics. The market research firm with a specialty in IVD made the assessment in its latest report The World Market for Point of Care Diagnostics.
According to the report, the top seven companies in POC testing are:
- Danaher (Beckman and Radiometer Divisions)
- Ascensia Diabetes Care
- Siemens Healthineers
The firm said 2016 revenues were used to make the assessment. Market share within POC categories can be found in Kalorama Information's report. The firm said that Roche dominated POC diagnostics as it leads in several IVD categories. Coagulation and glucose testing are key areas. In June 2015, Roche introduced the cobas c 513 blood glucose analyzer. It is a dedicated, high-throughput HbA1c analyzer suitable for diagnosis, monitoring and risk identification of diabetes patients.
Waltham, MA-based Alere secured the second market position Alere participates in nearly all POC test segments but has a dominating position in rapid cardiac markers, blood glucose including HbA1c, coagulation, drugs of abuse, infectious disease, lipid and pregnancy and fertility testing. The company has had challenges recently. The company said it was examining "inappropriate conduct" at the South Korean unit, Standard Diagnostics and federal investigations into Alere's government billing practices and foreign sales plagued the company last year. Yet in the point of care market, it is a dominant brand.
Abbott Laboratories, who had made a bid to acquire Alere last year, (now tied up in court and not likely to result in a merged company) held the third position. Abbott offers a good selection of POC tests. Abbott's strongest area of sales is in the blood glucose monitoring market. The introduction of the i-STAT Total β-hCG, a handheld blood test for pregnancy has helped POC sales for Abbott.
Danaher is fourth. Its Beckman Coulter unit participates in several POC testing segments and is a leader in POC blood and electrolytes testing, colon cancer screening, infectious disease and cancer testing markets. And Danaher's Radiometer participates in the blood and electrolytes and cardiac marker testing.
LifeScan is a leader in the blood glucose monitoring and large volume sales there put the company in fifth place. Participating companies in the blood glucose market have been targeted by generics and discounted products available online the company and its Ultra line was hard hit.
Ascensia Diabetes Care secured sixth place in the market due to the aforementioned issues in the glucose testing market. Siemens Healthineers is a major participant in POC testing for blood and electrolytes, rapid coagulation, rapid cardiac markers, drugs of abuse and urinalysis tests and earned seventh place.
The remaining market share is held by large, small and start-up companies including Abraxis, Accriva, bioMérieux, Ortho Diagnostics, Response Biomedical, Church & Dwight, Quidel, Prestige Brands, Meridian BioScience, Helena Labs, Polymedco, Enterix, Exact, OraSure, Trinity Biomedical, Abaxis, Polymer Technologies, EKF Diagnostics, Eiken Chemical, IL, Nova Biomedical, OPKO Health, Sysmex, and many others, Together these companies account for approximately $4.1 billion in revenues for 2016.
Kalorama Information's Point of Care (POC) Diagnostics is available at https://www.kaloramainformation.com/Point-Care-POC-10616559/.
More of Kalorama's diagnostics market reports can be found at: https://www.kaloramainformation.com/diagnostics-market-c1125/.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.
Please link any media or news references to our reports or data to http://www.kaloramainformation.com/.
212 807 2262
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kalorama-information-names-top-seven-companies-in-point-of-care-diagnostics-300422738.html
SOURCE Kalorama Information